P
PhageLab
Phage Lab is a laboratory dedicated to animal welfare, with solutions for the efficient control of bacteria in the poultry, cattle and aquaculture production systems industry
About PhageLab
PhageLab is a biotechnology company specializing in the development of sustainable, antibiotic-free solutions to control bacterial outbreaks in the livestock and poultry industries. Operating primarily in Latin America, PhageLab serves poultry and livestock producers by providing tailored bacteriophage cocktails that target specific bacterial pathogens. The company leverages its extensive collections of bacteria and phages, among the largest in the world, to create customized treatments that enhance animal health and food safety. PhageLab's business model involves a subscription-based service, allowing clients to receive regular updates and new formulations as needed. Revenue is generated through these subscriptions and the sale of diagnostic services, which include non-invasive protocols to detect and understand pathogenic bacteria without disrupting farm operations. By accelerating the development of these solutions, PhageLab contributes to a more sustainable and safer food production system.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2010
- Headquarters
- Macul, Chile
- Employees
- 97
- Open positions
- None listed
- Dealroom signal
- 57.0/100
- Industry
- Food
- Sub-industry
- AgriTech
- Sector
- Food, Biotechnology, Bacteria, Biotechnology in Food, Animal Farming
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| CONVERTIBLE✓Equity / VC | Dec 2025 | $3.5M | — | KaszeK Ventures | ↗ |
| GRANT✓Other financing | Oct 2024 | $110K | — | The Yield Lab | ↗ |
Growth signals
Latest recorded traffic for PhageLab is 1.5K monthly website visits, down 53.1% over the last three months. PhageLab's team declined 12.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Start-Up Chile
The Yield Lab
Series A1 investor entered at this stage
Series B and later4 investors entered at this stage
- KEKevin Efrusy
Nazca Ventures
Collaborative Fund
WaterLemon Ventures
Other known investors4 additional known investors
Cristian Hernandez-Cuevas
Humboldt Fund
Technology Pioneers | World Economic Forum
The Yield Lab Latam
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about PhageLab on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See PhageLab’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








